MSK and Absci partner to use generative AI to discover novel cancer therapies, combining expertise in oncology with AI's drug designing capabilities.
MSK's collaboration with Absci signifies a significant step in the realm of life sciences AI, aiming to lead in cancer care and AI integration.
The unique partnership signifies a groundbreaking approach in the industry, focusing on co-development and funding initiatives for drug discovery using AI.
Partnership born from discussions at a healthcare conference highlights the increasing role of AI in advancing medical research and innovation.
Collection
[
|
...
]